Published in Nephron on January 01, 1985
Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications. Pediatr Nephrol (2007) 0.96
Effect of topical anaesthetics on interstitial colloid osmotic pressure in human subcutaneous tissue sampled by wick technique. PLoS One (2012) 0.78
Oxidative Stress and Nuclear Factor κB (NF-κB) Increase Peritoneal Filtration and Contribute to Ascites Formation in Nephrotic Syndrome. J Biol Chem (2016) 0.75
Pathophysiology, Evaluation, and Management of Edema in Childhood Nephrotic Syndrome. Front Pediatr (2016) 0.75
Clonidine withdrawal. Mechanism and frequency of rebound hypertension. Br J Clin Pharmacol (1979) 2.72
Transluminal vascular stent for ostial atherosclerotic renal artery stenosis. Lancet (1995) 2.19
Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med (1999) 2.03
Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension. J Am Soc Nephrol (2001) 1.79
Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet (1999) 1.74
Partial remission of nephrotic syndrome in patient on long-term simvastatin. Lancet (1990) 1.71
Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia. A randomized placebo-controlled trial. Circulation (1999) 1.66
Standardized comparison of processing capacity and efficiency of five new-generation immunoassay analyzers. Clin Chem (2000) 1.64
Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation (1998) 1.61
Volume regulation in children with early relapse of minimal-change nephrosis with or without hypovolaemic symptoms. Lancet (1995) 1.56
Long-term survival rates in haemodialysis patients treated with strict volume control. Nephrol Dial Transplant (2006) 1.45
Blunted natriuretic response and low blood pressure after atrial natriuretic factor in early cirrhosis. Hepatology (1989) 1.42
Endothelin-1-induced vasopressor responses in essential hypertension. Hypertension (1997) 1.41
IgA-deposits in cutaneous blood-vessel walls and mesangium in Henoch-Schönlein syndrome. Lancet (1973) 1.40
Pathophysiology of acute renal failure in idiopatic nephrotic syndrome. Nephrol Dial Transplant (2001) 1.32
Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet (1995) 1.30
5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation (1998) 1.27
Daily home haemodialysis in The Netherlands: effects on metabolic control, haemodynamics, and quality of life. Nephrol Dial Transplant (1998) 1.19
Plasma aldosterone concentrations in chronic renal disease. Kidney Int (1982) 1.16
Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats. J Am Soc Nephrol (2000) 1.12
Functional relationships in the nephrotic syndrome. Kidney Int (1984) 1.10
Thrombosis and hemostasis in renal disease. Kidney Int (1994) 1.09
Long-term effects of arterial stenting on kidney function for patients with ostial atherosclerotic renal artery stenosis and renal insufficiency. J Am Soc Nephrol (2001) 1.06
Evaluation of lithium clearance as a marker of proximal tubule sodium handling. Kidney Int (1989) 1.06
Male gender increases sensitivity to proteinuria induced by mild NOS inhibition in rats: role of sex hormones. Am J Physiol Renal Physiol (2000) 1.03
Salt sensitivity of blood pressure in chronic renal failure. Evidence for renal control of body fluid distribution in man. Hypertension (1982) 1.02
Effects of reduced renal perfusion pressure and acute volume expansion on proximal tubule and whole kidney angiotensin II content in the rat. Kidney Int (1997) 1.02
Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant (1998) 1.00
A comparison between PTFE and denatured homologous vein grafts for haemodialysis access: a prospective randomised multicentre trial. The SMASH Study Group. Study of Graft Materials in Access for Haemodialysis. Eur J Vasc Endovasc Surg (1998) 0.99
Elevation of uric aicd clearance caused by inappropriate antidiuretic hormone secretion. Acta Med Scand (1972) 0.98
Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease. Kidney Int (1998) 0.98
Iso-oncotic volume expansion in the nephrotic syndrome. Clin Sci (Lond) (1993) 0.96
Colloid osmotic pressure in young analbuminemic rats. Am J Physiol (1989) 0.96
Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidaemia of nephrotic syndrome. Lancet (1988) 0.95
Hypoalbuminemia causes high blood viscosity by increasing red cell lysophosphatidylcholine. Kidney Int (1997) 0.95
Cardiovascular risk factors in renal transplant patients: cyclosporin A versus tacrolimus. J Am Soc Nephrol (2001) 0.93
Albumin-bound fatty acids induce mitochondrial oxidant stress and impair antioxidant responses in proximal tubular cells. Kidney Int (2006) 0.92
Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions. J Clin Invest (1994) 0.92
Hemodynamic patterns and spectral analysis of heart rate variability during dialysis hypotension. J Am Soc Nephrol (1999) 0.91
Graft surveillance: venous pressure, access flow, or the combination? Kidney Int (2001) 0.91
Estrogen induces glomerulosclerosis in analbuminemic rats. Kidney Int (1998) 0.91
Rise in blood pressure during hemodialysis-ultrafiltration: a "paradoxical" phenomenon? Int J Artif Organs (1996) 0.90
Pulmonary embolism after thrombolysis of hemodialysis grafts. J Am Soc Nephrol (1997) 0.90
Impaired chylomicron remnant clearance in familial combined hyperlipidemia. Arterioscler Thromb (1993) 0.90
Interactions of cyclosporin A and amlodipine: blood cyclosporin A levels, hypertension and kidney function. J Hypertens Suppl (1998) 0.90
Lithium clearance during the paradoxical natriuresis of hypotonic expansion in man. Kidney Int (1987) 0.90
Sodium balance in renal failure. A comparison of patients with normal subjects under extremes of sodium intake. Hypertension (1985) 0.90
Clinical evaluation of a new antihypertensive vasodilating agent PR--G 138 Cl. Br J Clin Pharmacol (1979) 0.90
Effects of endothelin-1 on renal function in humans: implications for physiology and pathophysiology. Kidney Int (1994) 0.90
Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin. J Hypertens (1998) 0.89
Early and late adjustment to potassium loading in humans. Kidney Int (1990) 0.89
Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrations. Kidney Int (1999) 0.89
Endothelin in renal pathophysiology: from experimental to therapeutic application. Kidney Int (1996) 0.88
Blood volume, colloid osmotic pressure and F-cell ratio in children with the nephrotic syndrome. Kidney Int (1996) 0.88
Cyclosporin A increases nitric oxide activity in vivo. Hypertension (1997) 0.87
Renal sodium handling in normal humans subjected to low, normal, and extremely high sodium supplies. Am J Physiol (1985) 0.87
High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients. J Am Soc Nephrol (1995) 0.87
Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion. Metabolism (1993) 0.87
Graft flow as a predictor of thrombosis in hemodialysis grafts. Kidney Int (1998) 0.87
One and three doses of propranolol a day in hypertension. Clin Pharmacol Ther (1980) 0.86
Plasma and blood volumes in patients with the nephrotic syndrome. Nephron (1984) 0.86
Renal sodium handling in children with nephrotic relapse: relation to hypovolaemic symptoms. Nephrol Dial Transplant (1996) 0.86
Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, risk factors and survival. Bone Marrow Transplant (2007) 0.86
Pathophysiology of edema formation in children with nephrotic syndrome not due to minimal change disease. J Am Soc Nephrol (1999) 0.86
Enalapril attenuates natriuresis of atrial natriuretic factor in humans. Hypertension (1988) 0.86
Nitric oxide, superoxide and renal blood flow autoregulation in SHR after perinatal L-arginine and antioxidants. Acta Physiol (Oxf) (2007) 0.86
Cefepime compared with ceftazidime as initial therapy for serious bacterial infections and sepsis syndrome. Antimicrob Agents Chemother (1994) 0.86
Effects of furosemide or acetazolamide infusion on renal handling of lithium: a micropuncture study in rats. Am J Physiol (1993) 0.85
A three-parameter Langmuir-type model for fitting standard curves of sandwich enzyme immunoassays with special attention to the alpha-fetoprotein assay. Anal Biochem (1987) 0.85
Evaluation of the lithium clearance method: direct analysis of tubular lithium handling by micropuncture. Kidney Int (1995) 0.85
Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects. Kidney Int (1999) 0.85
Losartan versus enalapril on cerebral edema and proteinuria in stroke-prone hypertensive rats. Am J Hypertens (2001) 0.85
Relevance of the tubuloglomerular feedback mechanism in pathophysiology. J Am Soc Nephrol (1993) 0.84
Paranormal healing and hypertension. Br Med J (Clin Res Ed) (1988) 0.84
Lowered tissue-fluid oncotic pressure protects the blood volume in the nephrotic syndrome. Nephron (1986) 0.84
The origin of urinary angiotensins in humans. J Am Soc Nephrol (1994) 0.84
Nifedipine improves endothelial function in hypercholesterolemia, independently of an effect on blood pressure or plasma lipids. Cardiovasc Res (1999) 0.84
Coombs-negative severe haemolytic anaemia in an immunocompetent adult following cytomegalovirus infection. Eur J Clin Microbiol Infect Dis (2004) 0.84
Lithium clearance during variations in sodium intake in man: effects of sodium restriction and amiloride. Eur J Clin Invest (1988) 0.83
Dietary sucrose does not increase twenty-four-hour ambulatory blood pressure in patients with either essential hypertension or polycystic kidney disease. J Hypertens (1999) 0.83
Haemodynamic and hormonal changes during acute and chronic diuretic treatment in essential hypertension. Eur J Clin Pharmacol (1981) 0.83
Impaired renal blood flow autoregulation in two-kidney, one-clip hypertensive rats is caused by enhanced activity of nitric oxide. J Am Soc Nephrol (2000) 0.83
Sympathetic overactivity in renal failure controlled by ACE inhibition: clinical significance. Nephrol Dial Transplant (2000) 0.83